Dr. Prerna Mewawalla is a board-certified hematologist-oncologist and nationally recognized plasma cell disorder specialist focused on multiple myeloma, AL amyloidosis and MGUS. She serves as Director of the Stem Cell Transplantation and Cellular Therapy Program at AHN and is Associate Professor at Drexel University College of Medicine. Dr. Mewawalla leads clinical trials of CAR T-cell therapy, bispecific antibodies, stem cell transplantation and novel therapies. Her scholarly work, national and international presentations, honors and service on ACMS board of directors reflect her commitment to advancing plasma cell disorder care. She guides patients through complex treatment decisions with compassionate, personalized care.